European “Substances Of Very High Concern” List Published; Now What?
This article was originally published in The Gray Sheet
Executive Summary
U.S. device manufacturers are pushing for more guidance on ways to comply with new European requirements for devices containing chemicals classified as "substances of very high concern.
You may also be interested in...
FDA Task Force Takes Hard Look At Leachable Chemical In Medical Products
FDA is stepping up research into a chemical used in some plastics, including medical devices, in the wake of a recent National Institutes of Health brief outlining related safety concerns
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.